SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

MaxCyte Reports Q3 Revenue of $10.2 Million, Raises 2026 Guidance

MaxCyte reported $8.2 million in core revenue and $2.0 million in SPL Program-related revenue for the quarter ended September 30, 2026. It raised full-year 2026 total revenue guidance to at least $34.5 million.

MXCT
SquawkNews Desk

MaxCyte, Inc. reported total revenue of $10.2 million for the third quarter ended September 30, 2026, consisting of $8.2 million in core revenue and $2.0 million in SPL Program-related revenue. Following these results, the company raised its full-year 2026 total revenue guidance to at least $34.5 million, signaling a projected return to annual revenue growth. Management highlighted strong momentum in its cell therapy partnerships and the adoption of its ExPERT platform.

The company also noted that its core revenue grew by approximately 15% year-over-year in the second half of 2026, exceeding initial expectations.

Related stories

US session market picture: S&P 500 -0.59%, Nasdaq 100 -0.77%; EUR/USD -0.29%, WTI -1.84%, WBD leads volume US session market picture. US index futures: S and P futures is down 0.59 percent, Nasdaq futures is down 0.77 percent, Dow futures is down 0.49 percent and Russell futures is down M impact | EQUITY | Nov 10, 2026, 03:02 PM UTC Anthropic IPO said to draw orders to cover available shares. L impact | EQUITY | Nov 10, 2026, 02:57 PM UTC European session market picture: S&P 500 -0.6%, Nasdaq 100 -1.02%; EUR/USD -0.2%, WTI -2.86%, BARC leads volume European session market picture. US index futures: S and P futures is down 0.6 percent, Nasdaq futures is down 1.02 percent, Dow futures is down 0.16 percent and Russell futures is M impact | EQUITY | Nov 10, 2026, 02:30 PM UTC DocGo Reports Q3 2026 Results, Begins CEO Transition DocGo projected 2026 revenue of approximately $300 million and reaffirmed adjusted EBITDA guidance for a loss of $17 million to $22 million. M impact | EQUITY | Nov 10, 2026, 02:05 PM UTC Highwood Asset Management Reports Third-Quarter 2026 Results Highwood reported EBITDA of $3.8 million ($0.25 per share), adjusted funds flow of $3.5 million ($0.23 per share) and average production of 2,494 boe/d for the quarter. Production M impact | EQUITY | Nov 10, 2026, 02:05 PM UTC ACCESS Newswire Reports Q3 Revenue of $5.5 Million Third-quarter revenue was $5.5 million versus $5.7 million a year earlier. Gross margin was 75%, up from 73% in the second quarter, while adjusted EBITDA fell to $829,000 from $933 M impact | EQUITY | Nov 10, 2026, 02:05 PM UTC